Nephrology
News
ADA updates on finerenone, SGLT2 inhibitors, and race-based eGFR
ADA has made an interim change to its latest Standards of Medical Care, an update based on trial evidence and consensus about finerenone, SGLT2...
Conference Coverage
Will tirzepatide slow kidney function decline in type 2 diabetes?
Compared to insulin glargine, tirzepatide was associated with significantly less new-onset macroalbuminuria in patients with T2D at high...
News
Mixing BP meds with NSAID may be ‘triple whammy’ for kidneys
In the absence of additional risk factors, there was no indication of an elevated risk for AKI when an ACE inhibitor and NSAID are combined.
Article
Substantially enlarged cardiac silhouette
This case highlights an impressive manifestation of a diagnosis that affects many people around the world.
News
Lowering BP according to newest guidance would cut CV events
Two-thirds of patients would need new or intensified hypertension treatment to reach an SBP less than 120 mm Hg, as set in the 2021 KDIGO...
News
Biomarkers predict cardiovascular risk in chronic kidney disease patients
New models to stratify atherosclerotic cardiovascular disease risk may improve shared decision-making.
News
No COVID vax, no transplant: Unfair or good medicine?
Is removing them from the list unfair and cruel, or simply business as usual?
News
Allopurinol found safe in patients with concomitant gout, CKD
Despite earlier concerns, a study has found no sign of increased mortality with allopurinol therapy in patients with gout and chronic kidney...
News
HIV+ patients get good outcomes after kidney or liver transplant
New research further supports the inclusion of people with HIV in transplant resource allocation.
Conference Coverage
Finerenone, sotagliflozin exert heart failure benefits despite renal dysfunction
Secondary trial analyses in patients with type 2 diabetes showed both finerenone and sotagliflozin had heart failure benefits across the spectrum...